Ritholtz Wealth Management Invests $396,000 in Henry Schein, Inc. $HSIC

Key Points

• Ritholtz Wealth Management invested approximately $396,000 in Henry Schein, Inc. by acquiring 5,418 shares during the second quarter.
• Henry Schein, Inc. reported a missed earnings estimate with $1.10 earnings per share for the last quarter, below the consensus of $1.19, despite a revenue increase to $3.24 billion.
• Analysts have predominantly rated Henry Schein as a "Hold," with updated price targets ranging from $70.00 to $76.00, reflecting adjustments from earlier valuations.

Ritholtz Wealth Management acquired a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 5,418 shares of the company's stock, valued at approximately $396,000.

A number of other institutional investors have also added to or reduced their stakes in the company. Steph & Co. bought a new position in shares of Henry Schein in the 2nd quarter valued at about $44,000. CX Institutional boosted its stake in shares of Henry Schein by 107.3% during the 2nd quarter. CX Institutional now owns 651 shares of the company's stock worth $48,000 after acquiring an additional 337 shares during the period. TD Private Client Wealth LLC increased its holdings in shares of Henry Schein by 103.0% during the 2nd quarter. TD Private Client Wealth LLC now owns 668 shares of the company's stock worth $49,000 after acquiring an additional 339 shares during the last quarter. Whittier Trust Co. raised its stake in Henry Schein by 714.3% in the 1st quarter. Whittier Trust Co. now owns 798 shares of the company's stock valued at $55,000 after acquiring an additional 700 shares during the period. Finally, Quarry LP bought a new stake in Henry Schein in the 1st quarter valued at $71,000. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Stock Performance

NASDAQ HSIC opened at $63.93 on Tuesday. The firm has a 50-day moving average price of $67.07 and a two-hundred day moving average price of $68.59. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The company has a market capitalization of $7.75 billion, a P/E ratio of 20.62, a P/E/G ratio of 2.08 and a beta of 0.81. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). The business had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The firm's quarterly revenue was up 3.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.23 earnings per share. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have commented on HSIC. Robert W. Baird reiterated a "neutral" rating and issued a $72.00 price objective (down from $82.00) on shares of Henry Schein in a report on Monday, July 14th. UBS Group reduced their target price on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a report on Wednesday, August 6th. Baird R W cut shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a report on Monday, July 14th. Stifel Nicolaus restated a "hold" rating and set a $75.00 price objective (down from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Finally, JPMorgan Chase & Co. decreased their target price on Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a research report on Thursday, August 7th. Five research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $76.67.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.